Article Versions Notes

Voges ARN, Ubukata R, Yazbek KVB, Caballero OL, Salazar AM, Massoco CdO, Dagli MLZ. Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events. Cancers. 2021; 13(9):2237. https://doi.org/10.3390/cancers13092237

Voges, Alessandra Rinah Nogueira, Rodrigo Ubukata, Karina Velloso Braga Yazbek, Otávia Luisa Caballero, Andres Mario Salazar, Cristina de Oliveira Massoco, and Maria Lucia Zaidan Dagli. 2021. "Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events" Cancers 13, no. 9: 2237. https://doi.org/10.3390/cancers13092237

Voges, A. R. N., Ubukata, R., Yazbek, K. V. B., Caballero, O. L., Salazar, A. M., Massoco, C. d. O., & Dagli, M. L. Z. (2021). Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events. Cancers, 13(9), 2237. https://doi.org/10.3390/cancers13092237